Treatment of scleromyxedema with 2-chlorodeoxyadenosine
- 31 August 1996
- journal article
- case report
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 35 (2) , 288-290
- https://doi.org/10.1016/s0190-9622(96)90650-7
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- 2-Chlorodeoxyadenosine-Induced Complete Remissions in Langerhans-Cell HistiocytosisAnnals of Internal Medicine, 1994
- Cladribine in treatment of chronic progressive multiple sclerosisThe Lancet, 1994
- 2-Chlorodeoxyadenosine: A Newer Purine Analog Active in the Treatment of Indolent Lymphoid MalignanciesAnnals of Internal Medicine, 1994
- The association of potentially lethal neurologic syndromes with scleromyxedema (papular mucinosis)Journal of the American Academy of Dermatology, 1993
- Potent toxicity of 2-chlorodeoxyadenosine toward human monocytes in vitro and in vivo. A novel approach to immunosuppressive therapy.Journal of Clinical Investigation, 1990
- Successful treatment of scleromyxedema with plasmapheresis and immunosuppressionJournal of the American Academy of Dermatology, 1990
- Scleromyxoedema—successful treatment with plasma exchange and immunosuppressionBritish Journal of Dermatology, 1987
- Lichen Myxedematosus Serum Stimulates Human Skin Fibroblast ProliferationScience, 1978
- Lichen MyxedematosusArchives of Dermatology, 1975